Characterization of the circulating serum amyloid A in bottlenose dolphins

Veterinary Immunology and Immunopathology

Volumn 152, Issue 3-4, 2013, Pages 218-224

  Segawa, Takao ^a   Otsuka, Toru ^a   Itou, Takuya ^a   Suzuki, Miwa ^a   Karatani, Nana ^a   Sakai, Takeo ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Dolphin; Isoform; Serum amyloid A

Indexed keywords

ISOPROTEIN; LIVER PROTEIN; MESSENGER RNA; SERUM AMYLOID A; SERUM AMYLOID A 1; SERUM AMYLOID A 2; SERUM AMYLOID A 3; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BOTTLENOSE DOLPHIN; CONTROLLED STUDY; INFLAMMATION; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN MOTIF; WESTERN BLOTTING;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BOTTLE-NOSED DOLPHIN; CLONING, MOLECULAR; DNA, COMPLEMENTARY; INFLAMMATION MEDIATORS; ISOELECTRIC POINT; LIVER; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN ISOFORMS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SERUM AMYLOID A PROTEIN; TISSUE DISTRIBUTION;

ANIMALIA; MAMMALIA; SUIDAE; TURSIOPS;

EID: 84875537494     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.12.006     Document Type: Article

References (29)

1. Badolato R., Wang J.M., Murphy W.J., Lloyd A.R., Michiel D.F., Bausserman L.L., Kelvin D.J., Oppenheim J.J. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 1994, 180:203-209.
2. Badolato R., Wang J.M., Stornello S.L., Ponzi A.N., Duse M., Musso T. Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity. J. Leukoc. Biol. 2000, 67:381-386.
3. Berg L.C., Thomsen P.D., Andersen P.H., Jensen H.E., Jacobsen S. Serum amyloid A is expressed in histologically normal tissues from horses and cattle. Vet. Immunol. Immunopathol. 2011, 144:155-159.
4. Bossart G.D., Reidarson T.H., Dierauf L.A., Duffield D.A. Clinical pathology. CRC Handbook of Marine Mammal Medicine 2001, 383-436. CRC Press, Boca Raton, London, New York, Washington, DC, USA. second edition. L. Gulland (Ed.).
5. Domenech A., Raynes J.G., Rodriguez E.G., Aris A., Bach A., Serrano A. Recombinant expression of goat milk serum amyloid A: preliminary studies of the protein and derived peptides on macrophage phagocytosis. Protein Pept. Lett. 2012, 19:299-307.
6. Dunn J.L., Buck J.D., Robeck T.R. Bacterial diseases of cetaceans and pinnipeds. CRC Handbook of Marine Mammal Medicine, 2001, 309-336. CRC Press, Boca Raton, London, New York, Washington, DC, USA. second edition. L. Gulland (Ed.).
7. Eckersall P.D., Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Vet. J. 2010, 185:23-27.
8. Gardiner G.E., O'Flaherty S., Casey P.G., Weber A., McDonald T.L., Cronin M., Hill C., Ross R.P., Gahan C.G., Shanahan F. Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection: in vitro and in murine models of intestinal disease. FEMS Immunol. Med. Microbiol. 2009, 55:404-413.
9. Jacobsen S., Niewold T.A., Halling-Thomsen M., Nanni S., Olsen E., Lindegaard C., Andersen P.H. Serum amyloid A isoforms in serum and synovial fluid in horses with lipopolysaccharide-induced arthritis. Vet. Immunol. Immunopathol. 2006, 110:325-330.
10. Jacobsen S., Niewold T.A., Kornalijnslijper E., Toussaint M.J., Gruys E. Kinetics of local and systemic isoforms of serum amyloid A in bovine mastitic milk. Vet. Immunol. Immunopathol. 2005, 104:21-31.
11. King D.P., Aldridge B.M., Keennedy-Stoskopf S., Stott J.L. Immunology. CRC Handbook of Marine Mammal Medicine 2001, 237-252. CRC Press, Boca Raton, London, New York, Washington, DC, USA. second edition. L. Gulland (Ed.).
12. Kjelgaard-Hansen M., Christensen M.B., Lee M.H., Jensen A.L., Jacobsen S. Serum amyloid A isoforms in serum and synovial fluid from spontaneously diseased dogs with joint diseases or other conditions. Vet. Immunol. Immunopathol. 2007, 117:296-301.
13. Larson M.A., Wei S.H., Weber A., Mack D.R., McDonald T.L. Human serum amyloid A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence. Biochem. Biophys. Res. Commun. 2003, 300:531-540.
14. Linke R.P., Bock V., Valet G., Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem. Biophys. Res. Commun. 1991, 176:1100-1105.
15. Mack D.R., McDonald T.L., Larson M.A., Wei S., Weber A. The conserved TFLK motif of mammary-associated serum amyloid A3 is responsible for up-regulation of intestinal MUC3 mucin expression in vitro. Pediatr. Res. 2003, 53:137-142.
16. Marhaug G., Hackett B., Dowton S.B. Serum amyloid A gene expression in rabbit, mink and mouse. Clin. Exp. Immunol. 1997, 107:425-434.
17. McDonald T.L., Larson M.A., Mack D.R., Weber A. Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A 3 (M-SAA3) into colostrum. Vet. Immunol. Immunopathol. 2001, 83:203-211.
18. Meek R.L., Eriksen N., Benditt E.P. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:7949-7952.
19. Molenaar A.J., Harris D.P., Rajan G.H., Pearson M.L., Callaghan M.R., Sommer L., Farr V.C., Oden K.E., Miles M.C., Petrova R.S., Good L.L., Singh K., McLaren R.D., Prosser C.G., Kim K.S., Wieliczko R.J., Dines M.H., Johannessen K.M., Grigor M.R., Davis S.R., Stelwagen K. The acute-phase protein serum amyloid A3 is expressed in the bovine mammary gland and plays a role in host defence. Biomarkers 2009, 14:26-37.
20. Patel H., Fellowes R., Coade S., Woo P. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 1998, 48:410-418.
21. Rokita H., Shirahama T., Cohen A.S., Meek R.L., Benditt E.P., Sipe J.D. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes. J. Immunol. 1987, 139:3849-3853.
22. Segawa T., Itou T., Echigoya Y., Suzuki M., Koie H., Sakai T. Molecular cloning and expression of bottlenose dolphin CD34. Vet. Immunol. Immunopathol. 2010, 139:303-307.
23. Soler L., Luyten T., Stinckens A., Buys N., Ceron J.J., Niewold T.A. Serum amyloid A3 (SAA3), not SAA1 appears to be the major acute phase SAA isoform in the pig. Vet. Immunol. Immunopathol. 2011, 141:109-115.
24. Su S.B., Gong W., Gao J.L., Shen W., Murphy P.M., Oppenheim J.J., Wang J.M. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 1999, 189:395-402.
25. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL-W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
26. Uhen M.D. Evolution of marine mammals: back to the sea after 300 million years. Anat. Rec. (Hoboken) 2007, 290:514-522.
27. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 1999, 265:501-523.
28. Vallon R., Freuler F., Desta-Tsedu N., Robeva A., Dawson J., Wenner P., Engelhardt P., Boes L., Schnyder J., Tschopp C., Urfer R., Baumann G. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 2001, 166:2801-2807.
29. Zimlichman S., Danon A., Nathan I., Mozes G., Shainkin-Kestenbaum R. Serum amyloid A, an acute phase protein, inhibits platelet activation. J. Lab. Clin. Med. 1990, 116:180-186.